LAKE FOREST, Ill., and
KANSAS CITY, Mo., Aug. 25, 2015 /PRNewswire/ -- Hospira, Inc.
(NYSE: HSP), the world's leading provider of injectable drugs and
infusion technologies, and Cerner (NASDAQ: CERN), a global leader
in healthcare technology, today announced a commitment to advance
the integration of I.V.-EMR technology. The expanded agreement
strengthens both companies' ability to continue to bring innovative
technologies to market, designed to enhance interoperability
between Hospira's smart intravenous (I.V.) infusion devices and
Cerner's CareAware® solutions to meet the
evolving needs of healthcare organizations.
Cerner's CareAware technology is supplier-neutral and
enables interoperability among medical devices, healthcare
applications and electronic medical record (EMR) platforms. With
Cerner's CareAware programming, Hospira will connect its
infusion pumps to the EMR at the point of care and add
functionality for devices connecting to
CareAware.
"Hospira is proud to extend our relationship with Cerner to
deliver the enhanced interoperability between smart I.V. pumps and
EMRs that our customers seek," said Cynthia
Ansari, vice president, U.S. Marketing and Software, Medical
Devices, Hospira. "Together, we will innovate to enable our
products to integrate in new and even more effective ways. This
relationship builds on a longstanding foundation of collaboration
between our companies with a shared goal of supporting healthcare
organizations and caregivers in delivering the best possible
care."
The new agreement focuses on broadening interoperability among
Hospira's portfolio of smart infusion pumps with Hospira MedNet™
safety software and Cerner's Millennium™ healthcare
information technology (IT) platform. Among other capabilities,
I.V.-EMR interoperability enables electronic association of
patient, device and medication. Cerner CareAware
iBus® technology permits infusion pumps to be
automatically programmed with pharmacy validated medication orders
from the EMR, and infusion therapy data from the pump to be
automatically documented in the EMR.
"Cerner's CareAware is a powerful tool for creating a
connected healthcare experience, regardless of a provider's many
technology partners," said Bryce
Turnbull, vice president of Cerner DeviceWorks. "Through our
work with Hospira, Cerner is helping provide caregivers the patient
data they need to make more informed care decisions, which lead to
better patient outcomes."
Hospira and Cerner first collaborated in 2003 to develop
infusion pump and EMR integration technology, also known as
I.V.-EMR interoperability. Hospira has since deployed I.V.-EMR
interoperability at more hospitals than any other smart pump
vendor.1
About Hospira
Hospira, Inc. is the world's leading provider of injectable
drugs and infusion technologies, and a global leader in
biosimilars. Through its broad, integrated portfolio, Hospira is
uniquely positioned to Advance Wellness™ by improving patient and
caregiver safety while reducing healthcare costs. The company is
headquartered in Lake Forest, Ill.
Learn more at www.hospira.com.
About Cerner
Cerner's health information technologies connect people,
information, and systems, at more than 18,000 facilities worldwide.
Recognized for innovation, Cerner solutions assist clinicians in
making care decisions and enable organizations to manage the health
of populations. The company also offers an integrated clinical and
financial system to help healthcare organizations manage revenue,
as well as a wide range of services to support clients' clinical,
financial and operational needs. Cerner's mission is to contribute
to the systemic improvement of healthcare delivery and the health
of communities. For more information about Cerner, visit
www.cerner.com, read our blog at www.cerner.com/blog, connect with
us on Twitter at http://www.twitter.com/cerner and on Facebook
at www.facebook.com/cerner.
-- Private Securities Litigation Reform Act of
1995 --
A Caution Concerning Forward-Looking
Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. Forward-looking
statements generally relate to future events or Hospira's future
financial or operating performance. In some cases, you can identify
forward-looking statements because they contain words such as
"may," "will," "should," "expects," "plans," "anticipates,"
"could," "intends," "target," "projects," "contemplates,"
"believes," "estimates," "predicts," "potential" or "continue" or
the negative of these words or other similar terms or expressions
that concern Hospira's expectations, strategy, plans or intentions.
Forward-looking statements in this press release include Hospira's
expectations regarding regulatory approvals, clinical trials and
the actions of competitors. Hospira's expectations and beliefs
regarding these matters may not materialize, and actual results in
future periods are subject to risks and uncertainties that could
cause actual results to differ materially from those projected.
Actual results may differ materially from those indicated by these
forward-looking statements as a result of various important
factors, including, without limitation, challenges inherent in
creating and developing compounds and product candidates and
economic, competitive, governmental, regulatory, legal, supply and
other factors. Information on these and additional risks affecting
Hospira's business and operating results are more fully discussed
in the section entitled "Risk Factors" in Hospira's most recently
filed annual report on Form 10-K and any subsequently filed
quarterly report on Form 10-Q. The forward-looking statements in
this press release are based on information available as of the
date hereof, and Hospira disclaims any obligation to update any
forward-looking statements, except as required by law.
1. Hess P. Smart Pump/EMR
Integration - What Are My Best Options? May
2015 Performance Report. Available at
www.klasresaerch.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/hospira-and-cerner-expand-agreement-to-advance-integration-of-iv-emr-technology-300132513.html
SOURCE Hospira, Inc.